ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages

被引:90
作者
Von Eckardstein, A
Langer, C
Engel, T
Schaukal, I
Cignarella, A
Reinhardt, R
Lorkowski, S
Li, ZC
Zhou, XQ
Cullen, P
Assmann, G
机构
[1] Univ Munster, Cent Lab, Inst Clin Chem & Lab Med, D-48129 Munster, Germany
[2] Inst Arteriosclerosis Res, D-48149 Munster, Germany
[3] Univ Milan, Inst Pharmacol Sci, I-20133 Milan, Italy
[4] Univ Munster, Inst Physiol, D-48129 Munster, Germany
关键词
ABCA1; Tangier disease; apoE;
D O I
10.1096/fj.00-0798com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein E (apoE) produced by macrophages in the arterial wall protects against atherosclerosis, but the regulation of its secretion by these cells is poorly understood. Here we investigated the contribution of the adenosine triphosphate binding cassette transporters ABCA1 and ABC8 to the secretion of apoE from either primary human monocyte-derived macrophages (HMDM) or human THP1 macrophages. During incubations of up to 6 h, apoE secretion from both THP1 macrophages and HMDM was stimulated by 8-Br-cAMP, which activates ABCA1 expression. The putative ABCA1 inhibitor glyburide and antisense oligonucleotides directed against ABCA1 mRNA significantly reduced apoE secretion from THP1 macrophages and HMDM. Antisense oligonucleotides directed against ABC8 mRNA also inhibited apoE secretion, although this inhibition was less pronounced and consistent than in the case of ABCA1. ApoE secretion from HMDM of ABCA1-deficient patients with Tangier disease was also decreased. ApoE mRNA expression was not affected by inhibition of ABCA1 or ABC8 in normal HMDM or the lack of functional ABCA1 in HMDM from Tangier disease patients. Inhibition of ABCA1 in HMDM prevented the occurrence of anti-apoE-immunoreactive granular structures in the plasma membrane. We conclude that ABCA1 and, to a lesser extent, ABC8 both promote secretion of apoE from human macrophages.
引用
收藏
页码:1555 / 1561
页数:7
相关论文
共 49 条
[1]   The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles [J].
Andrei, C ;
Dazzi, C ;
Lotti, L ;
Torrisi, MR ;
Chimini, G ;
Rubartelli, A .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (05) :1463-1475
[2]  
Assman G, 2001, METABOLIC MOL BASES, P2937
[3]   ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes [J].
Becq, F ;
Hamon, Y ;
Bajetto, A ;
Gola, M ;
Verrier, B ;
Chimini, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) :2695-2699
[4]   MACROPHAGE-SPECIFIC EXPRESSION OF HUMAN APOLIPOPROTEIN-E REDUCES ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC APOLIPOPROTEIN E-NULL MICE [J].
BELLOSTA, S ;
MAHLEY, RW ;
SANAN, DA ;
MURATA, J ;
NEWLAND, DL ;
TAYLOR, JM ;
PITAS, RE .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2170-2179
[5]  
Bielicki JK, 1999, J LIPID RES, V40, P85
[6]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[7]   The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines [J].
Bortnick, AE ;
Rothblat, GH ;
Stoudt, G ;
Hoppe, KL ;
Royer, LJ ;
McNeish, J ;
Francone, OL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28634-28640
[8]   INTERFERON-GAMMA INHIBITS MACROPHAGE APOLIPOPROTEIN-E PRODUCTION BY POSTTRANSLATIONAL MECHANISMS [J].
BRAND, K ;
MACKMAN, N ;
CURTISS, LK .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2031-2039
[9]  
BROWN MS, 1980, J BIOL CHEM, V255, P9344
[10]   Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages [J].
Cullen, P ;
Cignarella, A ;
Brennhausen, B ;
Mohr, S ;
Assmann, G ;
von Eckardstein, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1670-1677